Followers | 261 |
Posts | 33820 |
Boards Moderated | 2 |
Alias Born | 01/24/2013 |
Tuesday, May 09, 2017 8:25:49 PM
First of all, I think that statement is too much of a generalization.
They have shown that they are interested in MANY different aspects of medicine. So to say that they only want CBD to fund Cancer Research, is not accurate. One of the reasons maybe, but more in general, I think they recognized that much of what they want to do is going to take much longer than they originally thought.
So maybe the timing of CBD is to keep the company running without staying in debt, while supplying a product that is already in their wheelhouse, Pain Relief.
I still believe the MAIN thing holding up the cancer end of this is a PATENT. With a patent, money would be no object. As money would be flying at them from Big Pharma in the form of a partnership.
I can't say it enough, evidently, without a patent, this goes nowhere.
Who would spend money on trials without patent protection?
As of just now the re-submission has not been sent in. The last entry is the "Final Rejection" on 03-31-17
I believe the only thing in their immediate future is making a success out of the CBD line.
Just My Own Opinion.
You'll need STRONG HANDS to hold the bag that others are selling you!
If you are going to tell others which stocks to buy and which to sell, are you therefore going to cover their losses if you are wrong?
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM